◼ Archived
Business
🔮 fades
Abbott Reports Second-Quarter 2026 Results and Raises Full-Year EPS Guidance
Abbott Laboratories boosts its 2026 full-year profit guidance after reporting stronger-than-expected second-quarter sales and earnings.